Michael Miller
Director/Board Member presso PUMA BIOTECHNOLOGY, INC.
Patrimonio netto: 229 797 $ in data 31/03/2024
Profilo
Michael Patrick Miller currently works at Puma Biotechnology, Inc., as Independent Director from 2018, BioXcel Therapeutics, Inc., as Independent Director from 2022, and Zane Beadles Parade Foundation, as Director.
Mr. Miller also formerly worked at The Leukemia & Lymphoma Society, Inc., as Director, Allena Pharmaceuticals, Inc., as Director, ALZA Corp., as Vice President from 1997 to 2001, Genentech, Inc., as Vice President-Sales & Marketing from 2006 to 2010, Cellegy Pharmaceuticals, Inc., as Vice President-Commercial Operations, VIVUS, Inc., as Chief Commercial Officer & Senior Vice President from 2010 to 2014, Connetics Corp., as Senior Vice President-Sales & Marketing from 2003 to 2005, and Jazz Pharmaceuticals Plc, as Executive Vice President-Commercial from 2017 to 2020.
Mr. Miller received his undergraduate degree and graduate degree from Duke University, Masters Business Admin degree from San Francisco State University, and undergraduate degree from the University of San Francisco.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
0.09% | 07/11/2023 | 43 358 ( 0.09% ) | 229 797 $ | 31/03/2024 |
Posizioni attive di Michael Miller
| Società | Posizione | Inizio |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Director/Board Member | 23/02/2018 |
| BIOXCEL THERAPEUTICS, INC. | Director/Board Member | 01/07/2022 |
| Zane Beadles Parade Foundation | Director/Board Member | - |
Precedenti posizioni note di Michael Miller
| Società | Posizione | Fine |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 31/03/2020 |
| VIVUS, INC. | Corporate Officer/Principal | 16/01/2014 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Sales & Marketing | 01/04/2010 |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Sales & Marketing | 01/12/2005 |
| ALZA CORPORATION | Corporate Officer/Principal | 01/01/2001 |
Formazione di Michael Miller
| Duke University | Graduate Degree |
| San Francisco State University | Masters Business Admin |
| University of San Francisco | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Cellegy Pharmaceuticals, Inc.
 Cellegy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cellegy Pharmaceuticals specialty biopharmaceutical company, that is primarily engaged in the development and commercialization of prescription drugs targeting women’s health care, including reduction in transmission of HIV and female sexual dysfunction, and gastrointestinal conditions using proprietary topical formulations and nitric oxide, or NO, donor technologies | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
| Zane Beadles Parade Foundation |
- Borsa valori
- Insiders
- Michael Miller
